You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 22, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Christoph Sommer1, Rudolf Hoefler1, Matthias Samwer1
1Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), 1030 Vienna, Austria.
Supervised machine learning for high-content screening has limitations. CellCognition Explorer, a novel deep learning framework, discovers rare cell phenotypes without prior user training, improving assay development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: